Please note: The University of Texas Health Science Center at San Antonio will now be called "UT Health San Antonio."
Current search filters:
Filter by Program : PhD/IBMS
IBMS : Physiology and Pharmacology
Filter and narrow down your results by the options to the left
Muhammed Abdul-Ghani, M.D., Ph.D.
The seminal studies of Dr. Muhammad Abdul-Ghani have helped define the role of progressive beta cell failure in the evolution...
Armen Akopian, Ph.D.
(Endodontics) – modulation of inflammatory and neuropathic pain
Greg Aune, M.D./ Ph.D.
Swati Banerjee, Ph.D.
Kelly Berg, Ph.D.
(Pharmacology) – G protein-coupled receptors, signal transduction, ligand functional selectivity
Manzoor Bhat, M.S., Ph.D.
(Cellular & Integrative Physiology) – molecular neuron-glia interactions, synaptic development and neurological disorders
Jean Bopassa, M.S., Ph.D.
Robert Brenner, Ph.D.
(Cellular & Integrative Physiology) – Integrative physiology and biophysics of ion channel structure and cellular signaling
José E. Cavazos, M.D., Ph.D.
(Neurology) – hippocampal plasticity; mechanisms of neuronal hyperexcitability, epilepsy
T. Arthur Chang, Ph.D., HCLD, ELD, CC
William Clarke, Ph.D.
(Pharmacology) – molecular and cellular mechanisms of drug efficacy and differential signal transduction
Gregory Collins, Ph.D.
(Pharmacology) – determinants of drug-seeking and drug-taking of abused substances, such as “bath salts”
Lynette C. Daws, Ph.D.
(Cellular & Integrative Physiology) – regulation of monoamine transporters, psychotherapeutic drug effects
Ralph A. DeFronzo, M.D.
Bruno Doiron, Ph.D.
Donald M. Dougherty, Ph.D.
Marc D. Feldman, M.D.
Charles P. France, Ph.D.
(Pharmacology) – behavioral and pharmacological factors influencing the abuse liability of drug
Alan Frazer, Ph.D.
(Pharmacology) – mechanisms of action of antidepressant drugs, regulation of serotonin transporter function
Teppei Fujikawa, Ph.D.
Veronica Galvan, Ph.D.
Physiology - Alzheimer's disease, nervous system, aging, mTOR pathway, stem cell.
Lisa R. Gerak, Ph.D.
(Pharmacology) – behavioral pharmacology of the GABAA receptor, with an emphasis on the effects of ethanol and neuroactive stero
Rita Ghosh, Ph.D.
Urology - Melanoma, DNA damage, genitourinary and skin cancer.
Andrea Giuffrida, Ph.D.
(Pharmacology) – Cannabinoid regulation of basal ganglia function and implications for Parkinson’s disease and Schizophrenia
Georgianna Gould, Ph.D.
Kenneth M. Hargreaves, D.D.S., Ph.D.
(Endodontics) – neuropharmacology of primary nociceptors and pain sensitivity
Stephen E. Harris, Ph.D.
Periodontics - BMP2 mechanisms and osteocyte function.
Peter J. Hornsby, Ph.D.
Martin Javors, Ph.D.
Nathaniel A. Jeske, Ph.D.
(Oral and Maxillofacial Surgery) – biochemical modulation of peripheral pain in nociceptive neurons by regulation of TRPV1 chann
Jun Hee Kim, Ph.D.
(Cellular & Integrative Physiology) – myelination and regulation of neuronal excitability and synaptic transmission
Wouter Koek, Ph.D.
(Psychiatry) – animal models of drug abuse, subjective effects and treatments
Yui-Wing Francis Lam, Ph.D.
Richard J. Lamb, Ph.D.
(Psychiatry) – behavioral pharmacology and neurobiology of drug addiction and treatment
Hye Young Lee, Ph.D.
(Cellular & Integrative Physiology) – ion channel dysregulation in mouse models of FXS and other developmental disorders
Feng Liu, Ph.D.
Daniel J. Lodge, Ph.D.
(Pharmacology) – Hippocampal and other afferent regulation of mesolimbic dopamine activity
Susan L. Mooberry, Ph.D.
David A. Morilak, Ph.D.
(Pharmacology) – brain norepinephrine in the stress response, anxiety and antidepressant drug action
James F. Nelson, Ph.D.
Luke Norton, Ph.D.
Diabetes - Molecular biology, genetics, and physiology of insulin resistance and type-2-diabetes.
Jason O’Connor, Ph.D.
(Pharmacology) – Tryptophan metabolism and mechanisms linking neuroinflammation and depression
Martin Paukert, M.D.
(Cellular & Integrative Physiology) – Role of calcium signaling and neuron-astroglial interactions in neuromodulation and arousa
Jason Pugh, Ph.D.
(Cellular & Integrative Physiology) – Axonal plasticity, cellular computation and signal processing in neural circuits
Qitao Ran, Ph.D.
(Cell Systems and Anatomy) – role of mitochondrial oxidative stress in aging and Alzheimer’s Disease
April Risinger, Ph.D.
Shivani Ruparel, Ph.D.
Mark S. Shapiro, Ph.D.
(Cellular & Integrative Physiology) – ion channel physiology; regulation by intracellular signaling pathways and excitability
Yuguang (Roger) Shi, Ph.D.
Paula K. Shireman, M.D.
Surgery- Inflammatory-mediated mechanisms of angiogenesis.
Gek-Ming Sia, Ph.D.
(Pharmacology) – neurodevelopment, cortical synapse and circuit formation, synaptogenesis
Thomas J. Slaga, Ph.D.
James D. Stockand, Ph.D.
(Cellular & Integrative Physiology) – structure, function and regulation of ENaC/Degenerin sodium ion channels
J. Randy Strong, Ph.D.
(Pharmacology) – role of catecholamines in aging; regulation of tyrosine hydroxylase gene expression
Rajeshwar R. Tekmal, Ph.D.
Obstetrics and Gynecology - Growth factor/hormone crosstalk, signal transduction, steroid hormone co-activation.
Glenn M. Toney, Ph.D.
(Cellular & Integrative Physiology) – cellular, molecular and integrative mechanisms of sympathetic nervous system function
David S. Weiss, Ph.D.
(Cellular & Integrative Physiology) – GABA receptor structure and function
Chih-Ko Yeh, Ph.D., BDS
Mengwei Zang, M.D., Ph.D.
7703 Floyd Curl Dr, Mail Code 7819
San Antonio, TX 78229-3900
Phone: (210) 567-3709
FAX: (210) 567-3719
Report issues with this site
Copyright © 2013-2018 The University of Texas Health Science Center at San Antonio.
Links provided from university pages to other web sites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.